Development and field testing of a novel patient-reported outcome measure of dysphagia in patients with eosinophilic esophagitis

Alimentary Pharmacology and Therapeutics

Volumn 38, Issue 6, 2013, Pages 634-642

  Dellon, E S ^a   Irani, A M ^b   Hill, M R ^c   Hirano, I ^d  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

^c Meritage Pharma Inc   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTENT ANALYSIS; CONTENT VALIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DYSPHAGIA; DYSPHAGIA SYMPTOM QUESTIONNAIRE; EOSINOPHILIC ESOPHAGITIS; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; MULTICENTER STUDY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SCORING SYSTEM; STRAUMANN DYSPHAGIA INSTRUMENT; SYMPTOM ASSESSMENT;

EID: 84883050242     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12413     Document Type: Article

References (42)

1. Liacouras CA, Furuta GT, Hirano I, et al,. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011; 128: e6.
2. Attwood SE, Smyrk TC, Demeester TR, Jones JB,. Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome. Dig Dis Sci 1993; 38: 109-16.
3. Straumann A, Spichtin HP, Bernoulli R, Loosli J, Vogtlin J,. Idiopathic eosinophilic esophagitis: a frequently overlooked disease with typical clinical aspects and discrete endoscopic findings. Schweiz Med Wochenschr 1994; 124: 1419-29.
4. Kelly KJ, Lazenby AJ, Rowe PC, Yardley JH, Perman JA, Sampson HA,. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology 1995; 109: 1503-12.
5. Dellon ES,. Diagnosis and management of eosinophilic esophagitis. Clin Gastroenterol Hepatol 2012; 10: 1066-78.
6. Noel RJ, Putnam PE, Rothenberg ME,. Eosinophilic esophagitis. N Engl J Med 2004; 351: 940-1.
7. Hruz P, Straumann A, Bussmann C, et al,. Escalating incidence of eosinophilic esophagitis: A 20-year prospective, population-based study in Olten County, Switzerland. J Allergy Clin Immunol 2011; 128: 1349-1350.
8. Prasad GA, Alexander JA, Schleck CD, et al,. Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota. Clin Gastroenterol Hepatol 2009; 7: 1055-61.
9. Dellon ES, Gibbs WB, Fritchie KJ, et al,. Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2009; 7: 1305-13.
10. Prasad GA, Talley NJ, Romero Y, et al,. Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: a prospective study. Am J Gastroenterol 2007; 102: 2627-32.
11. Mackenzie SH, Go M, Chadwick B, et al,. Clinical trial: eosinophilic esophagitis in patients presenting with dysphagia: a prospective analysis. Aliment Pharmacol Ther 2008; 28: 1140-6.
12. Veerappan GR, Perry JL, Duncan TJ, et al,. Prevalence of eosinophilic esophagitis in an adult population undergoing upper endoscopy: a prospective study. Clin Gastroenterol Hepatol 2009; 7: 420-6.
13. Katzka DA,. Eosinophilic esophagitis: from Rookie of the year to household name. Clin Gastroenterol Hepatol 2009; 7: 370-1.
14. Liacouras CA, Spergel JM, Ruchelli E, et al,. Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol 2005; 3: 1198-206.
15. Dellon ES, Aderoju A, Woosley JT, Sandler RS, Shaheen NJ,. Variability in diagnostic criteria for eosinophilic esophagitis: a systematic review. Am J Gastroenterol 2007; 102: 2300-13.
16. Hirano I,. Therapeutic end points in eosinophilic esophagitis: is elimination of esophageal eosinophils enough? Clin Gastroenterol Hepatol 2012; 10: 750-2.
17. Dohil R, Newbury R, Fox L, Bastian J, Aceves S,. Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized placebo-controlled trial. Gastroenterology 2010; 139: 418-29.
18. Gupta SK, Collins MH, Lewis JD, Farber RH,. Efficacy and safety of oral budesonide suspension (OBS) in pediatric subjects with eosinophilic esophagitis (EoE): results from the double-blind placebo-controlled PEER study. Gastroenterology 2011; 140 (Suppl. 1): S179.
19. Straumann A, Conus S, Degen L, et al,. Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology 2010; 139: 1526-37.
20. Alexander JA, Jung KW, Arora AS, et al,. Swallowed fluticasone improves histologic but not symptomatic responses of adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2012; 10: e1.
21. Dellon ES, Sheikh A, Speck O, et al,. Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis. Gastroenterology 2012; 143: e1.
22. Assa'ad AH, Gupta SK, Collins MH, et al,. An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis. Gastroenterology 2011; 141: 1593-604.
23. Spergel JM, Rothenberg ME, Collins MH, et al,. Reslizumab in children and adolescents with eosinophilic esophagitis: Results of a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2012; 129: 456-63.
24. Straumann A, Bussmann C, Perkins MC, et al,. Treatment of eosinophilic esophagitis with the CRTH2-antagonist OCT000459: A novel therapeutic principle. Gastroenterology 2012; 142 (Suppl. 2): AB 856.
25. Furuta GT, Liacouras CA, Collins MH, et al,. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 2007; 133: 1342-63.
26. Peery AF, Shaheen NJ, Dellon ES,. Practice patterns for the evaluation and treatment of eosinophilic oesophagitis. Aliment Pharmacol Ther 2010; 32: 1373-82.
27. Sperry SL, Shaheen NJ, Dellon ES,. Toward uniformity in the diagnosis of eosinophilic esophagitis (EoE): the effect of guidelines on variability of diagnostic criteria for EoE. Am J Gastroenterol 2011; 106: 824-32.
28. Konikoff MR, Noel RJ, Blanchard C, et al,. A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology 2006; 131: 1381-91.
29. Aceves SS, Newbury RO, Dohil MA, Bastian JF, Dohil R,. A symptom scoring tool for identifying pediatric patients with eosinophilic esophagitis and correlating symptoms with inflammation. Ann Allergy Asthma Immunol 2009; 103: 401-6.
30. Pentiuk S, Putnam PE, Collins MH, Rothenberg ME,. Dissociation between symptoms and histological severity in pediatric eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2009; 48: 152-60.
31. Fiorentino R, Liu G, Pariser AR, Mulberg AE,. Cross-sector sponsorship of research in eosinophilic esophagitis: a collaborative model for rational drug development in rare diseases. J Allergy Clin Immunol 2012; 130: 613-6.
32. Rothenberg ME, Aceves S, Bonis PA, et al,. Working with the US Food and Drug Administration: progress and timelines in understanding and treating patients with eosinophilic esophagitis. J Allergy Clin Immunol 2012; 130: 617-9.
33. US Food and Drug Administration. Patient-reported outcome measures: Use in medical product development to support labeling claims. Available at: www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf. Accessed January 16, 2013.
34. Moawad FJ, Dias JA, Veerappan GR, Baker T, Maydonovitch CL, Comparison of aerosolized swallowed fluticasone to esomeprazole for the treatment of eosinophilic esophagitis Am J Gastroenterol, 2011; 106 (Suppl. 2): S12 (AB 30).
35. Grudell AB, Alexander JA, Enders FB, et al,. Validation of the Mayo Dysphagia Questionnaire. Dis Esophagus 2007; 20: 202-5.
36. McElhiney J, Lohse MR, Arora AS, et al,. The Mayo Dysphagia Questionnaire-30: documentation of reliability and validity of a tool for interventional trials in adults with esophageal disease. Dysphagia 2010; 25: 221-30.
37. Franciosi JP, Hommel KA, Debrosse CW, et al,. Development of a validated patient-reported symptom metric for pediatric eosinophilic esophagitis: qualitative methods. BMC Gastroenterol 2011; 11: 126.
38. Franciosi JP, Hommel KA, DeBrosse CW, et al,. Quality of life in paediatric eosinophilic oesophagitis: what is important to patients? Child Care Health Dev 2012; 38: 477-83.
39. Franciosi JP, Hommel KA, Greenberg AB, et al,. Development of the Pediatric Quality of Life InventoryTM Eosinophilic Esophagitis Module items: qualitative methods. BMC Gastroenterol 2012; 12: 135.
40. Taft TH, Kern E, Keefer L, Burstein D, Hirano I,. Qualitative assessment of patient-reported outcomes in adults with eosinophilic esophagitis. J Clin Gastroenterol 2011; 45: 769-74.
41. Taft TH, Kern E, Kwiatek MA, Hirano I, Gonsalves N, Keefer L,. The adult eosinophilic oesophagitis quality of life questionnaire: a new measure of health-related quality of life. Aliment Pharmacol Ther 2011; 34: 790-8.
42. Sperry SLW, Woosley JT, Shaheen NJ, Dellon ES,. Influence of race and gender on the presentation of eosinophilic esophagitis. Am J Gastroenterol 2012; 107: 215-21.